Bioequivalence Test for Risperdal 2mg of Janssen Korea
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to conduct the bioequivalence (biological equivalence of two
preparations of a drug) test in healthy adults with "Risperdal OD Tab. 2mg" of Janssen Korea
as the investigational drug and "Risperdal Quicklet Tab. 2mg" as the control drug.